| Polyethylene glycol-covered ultra-small Gd2O3 nanoparticles for positive contrast at 1.5 T magnetic resonance clinical scanning MA Fortin, RM Petoral, F Söderlind, A Klasson, M Engström, T Veres, ... Nanotechnology 18 (39), 395501, 2007 | 215 | 2007 |
| Synthesis and Characterization of Tb3+-Doped Gd2O3 Nanocrystals: A Bifunctional Material with Combined Fluorescent Labeling and MRI Contrast Agent … RM Petoral Jr, F Soderlind, A Klasson, A Suska, MA Fortin, N Abrikossova, ... The Journal of Physical Chemistry C 113 (17), 6913-6920, 2009 | 194 | 2009 |
| Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI L Faucher, M Tremblay, J Lagueux, Y Gossuin, MA Fortin ACS applied materials & interfaces 4 (9), 4506-4515, 2012 | 156 | 2012 |
| Size-controlled functionalized mesoporous silica nanoparticles for tunable drug release and enhanced anti-tumoral activity M Bouchoucha, MF Cote, R C.-Gaudreault, MA Fortin, F Kleitz Chemistry of Materials 28 (12), 4243-4258, 2016 | 134 | 2016 |
| Ultra‐small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI L Faucher, AA Guay‐Bégin, J Lagueux, MF Côté, E Petitclerc, MA Fortin Contrast media & molecular imaging 6 (4), 209-218, 2011 | 130 | 2011 |
| Mesoporous silica nanoparticles: selective surface functionalization for optimal relaxometric and drug loading performances M Bouchoucha, R C.‐Gaudreault, MA Fortin, F Kleitz Advanced Functional Materials 24 (37), 5911-5923, 2014 | 85 | 2014 |
| Enhanced Relaxometric Properties of MRI “Positive” Contrast Agents Confined in Three‐Dimensional Cubic Mesoporous Silica Nanoparticles R Guillet‐Nicolas, JL Bridot, Y Seo, MA Fortin, F Kleitz Advanced Functional Materials 21 (24), 4653-4662, 2011 | 85 | 2011 |
| Impact of agglomeration on the relaxometric properties of paramagnetic ultra-small gadolinium oxide nanoparticles L Faucher, Y Gossuin, A Hocq, MA Fortin Nanotechnology 22 (29), 295103, 2011 | 81 | 2011 |
| Gold nanoparticles in radiotherapy and recent progress in nanobrachytherapy M Laprise‐Pelletier, T Simão, MA Fortin Advanced healthcare materials 7 (16), 1701460, 2018 | 79 | 2018 |
| High Relaxivities and Strong Vascular Signal Enhancement for NaGdF4 Nanoparticles Designed for Dual MR/Optical Imaging R Naccache, P Chevallier, J Lagueux, Y Gossuin, S Laurent, ... Advanced Healthcare Materials 2 (11), 1478-1488, 2013 | 76 | 2013 |
| Multidentate block-copolymer-stabilized ultrasmall superparamagnetic iron oxide nanoparticles with enhanced colloidal stability for magnetic resonance imaging N Chan, M Laprise-Pelletier, P Chevallier, A Bianchi, MA Fortin, JK Oh Biomacromolecules 15 (6), 2146-2156, 2014 | 66 | 2014 |
| Surface modification of gadolinium oxide thin films and nanoparticles using poly (ethylene glycol)-phosphate AA Guay-Bégin, P Chevallier, L Faucher, S Turgeon, MA Fortin Langmuir 28 (1), 774-782, 2012 | 58 | 2012 |
| Approach to hemoptysis in the modern era S Gagnon, N Quigley, H Dutau, A Delage, M Fortin Canadian respiratory journal 2017, 2017 | 54 | 2017 |
| Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies R Guillet-Nicolas, M Laprise-Pelletier, MM Nair, P Chevallier, J Lagueux, ... Nanoscale 5 (23), 11499-11511, 2013 | 53 | 2013 |
| Tailored biological retention and efficient clearance of pegylated ultra-small MnO nanoparticles as positive MRI contrast agents for molecular imaging P Chevallier, A Walter, A Garofalo, I Veksler, J Lagueux, S Bégin-Colin, ... Journal of Materials Chemistry B 2 (13), 1779-1790, 2014 | 51 | 2014 |
| MnO-labeled cells: positive contrast enhancement in MRI M Létourneau, M Tremblay, L Faucher, D Rojas, P Chevallier, Y Gossuin, ... The journal of physical chemistry B 116 (44), 13228-13238, 2012 | 50 | 2012 |
| Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting M Bouchoucha, É Béliveau, F Kleitz, F Calon, MA Fortin Journal of Materials Chemistry B 5 (37), 7721-7735, 2017 | 46 | 2017 |
| Labelling chemistry and characterization of [90Y/177Lu]-DOTA-ZHER2: 342-3 Affibody molecule, a candidate agent for locoregional treatment of urinary bladder carcinoma MA Fortin, A Orlova, PU Malmström, V Tolmachev International journal of molecular medicine 19 (2), 285-291, 2007 | 46 | 2007 |
| Colloidal synthesis and characterization of ultrasmall perovskite GdFeO3 nanocrystals F Söderlind, MA Fortin, RM Petoral, A Klasson, T Veres, M Engström, ... Nanotechnology 19 (8), 085608, 2008 | 43 | 2008 |
| Low‐Dose Prostate Cancer Brachytherapy with Radioactive Palladium–Gold Nanoparticles M Laprise‐Pelletier, J Lagueux, MF Côté, T LaGrange, MA Fortin Advanced healthcare materials 6 (4), 1601120, 2017 | 40 | 2017 |
